Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its expensive nature presents a significant challenge to many.